Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcabene in pediatric NAFLD
NCT03436420Phase 2Terminated
- Sponsor
- Emory University
- Start
- Mar 2018
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcabene in non-alcoholic fatty liver disease (NAFLD), sponsored by Emory University. Started Mar 2018; status: terminated.
02
Drugs
gemcabene
03
Conditions
non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT03436420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03436420.